N. Osseigerning et al., SEX-DIFFERENCES IN COAGULATION AND FIBRINOLYSIS IN SUBJECTS WITH CORONARY-ARTERY DISEASE, Thrombosis and haemostasis, 79(4), 1998, pp. 736-740
Women with coronary artery disease (CAD) have a prognosis at least as
bad and possibly worse than men. Differences in classical risk factors
do not fully account for these findings and there is evidence that ci
rculating: levels of haemostatic factors may predict CAD risk. In this
study sex differences in haemostatic risk factors were examined in re
lation to coronary stenosis. 609 (420 men, 69%) subjects admitted for
coronary angiography for suspected CAD were recruited. Levels of Facto
r VII:C (FVII:C), fibrinogen plasminogen activator inhibitor-1 (PAI-1)
and von Willebrand factor (vWF) were estimated in 296 subjects from o
ne centre. Of these, women (n = 107) had higher levels of FVII:C (134%
vs 117%, p < 0.0005), and fibrinogen (3.4 g/l vs 3.2 g/l p = 0.01) th
an men (n = 189) and these differences remained after adjusting for ot
her covariates. In subjects with angiographically significant atheroma
these differences in haemostatic factors (n = 50 for women vs n = 147
for men) were exaggerated, (FVII:C 139% vs 117, p < 0.0001, fibrinoge
n 3.7 g/l vs 3.3 g/l p = 0.003), PAI-1 (26.2 ng/ml vs 19.7 ng/ml, p =
0.02) with a trend towards higher levels of vWF in the women. Women wi
th significant atheroma at angiography (n = 50) had higher levels of P
AI-1 (25.0 ng/ml vs 13.4 ng/ml p < 0.0001) and vWF (1.25 IU/ml vs 1.06
IU/ml, p = 0.02) and a trend towards higher levels of both fibrinogen
and FVII:C than women with normal or in significant coronary vessel d
isease (n = 57). Elevated circulating levels of PAI-1, vWF, fibrinogen
and FVII:C in women with angiographically proven CAD may contribute t
o an adverse cardiovascular risk factor profile and the poorer prognos
is in females than male patients with proven coronary artery disease.